Our new paper focuses on the conversation around novel cell-based therapies for COVID-19 patients. Within this paper we explore the efficacy and safety of these coronavirus treatments and discuss the importance of tightly-regulated “compassionate use” and adequate evidence regarding these cell-based approaches.